| Previous Close | 83.87 |
| Open | 84.04 |
| Bid | 71.12 x 1000 |
| Ask | 71.74 x 44000 |
| Day's Range | 84.01 - 85.00 |
| 52 Week Range | 24.55 - 92.97 |
| Volume | 2,284,835 |
| Avg. Volume | 1,730,284 |
| Market Cap | 102.41B |
| Beta | 0.73 |
| PE Ratio (TTM) | 11.74 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 3.30 (3.40%) |
| Ex-Dividend Date | 2017-05-16 |
| 1y Target Est | N/A |
- Motley Fool•1 hour ago
12 Flu Season Facts You Need to Know
Here's everything you've ever wanted to know about influenza and flu vaccines.
- Zacks•3 days ago
Alnylam/Sanofi's RNAi Drug Meets Endpoint in Study, Stock Up
Alnylam (ALNY) and partner Sanofi RNAi therapeutic patisiran met its primary efficacy endpoint and all secondary endpoints in the phase III APOLLO study.
- Zacks•3 days ago
Is Sanofi (SNY) a Great Stock for Value Investors?
Let's see if Sanofi (SNY) stock is a good choice for value-oriented investors right now from multiple angles.
